445680 — Curiox BioSystems Co Balance Sheet
0.000.00%
- KR₩338bn
- KR₩324bn
- KR₩7bn
Annual balance sheet for Curiox BioSystems Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 7,940 | 19,819 | 8,722 | 17,909 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 1,155 | 1,330 | 1,921 | 1,850 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 9,891 | 23,060 | 13,949 | 21,601 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 427 | 543 | 998 | 2,391 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 41,367 | 55,793 | 48,627 | 57,798 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 22,064 | 48,395 | 2,835 | 2,717 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Liabilities | 24,093 | 50,211 | 4,775 | 4,919 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
ESOP Debt Guarantee | ||||
Other Equity | ||||
Total Equity | 17,274 | 5,582 | 43,853 | 52,879 |
Total Liabilities & Shareholders' Equity | 41,367 | 55,793 | 48,627 | 57,798 |
Total Common Shares Outstanding |